About Cerner (NASDAQ:CERN)
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company's segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, the Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The Company's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform.
Industry, Sector and Symbol
Industry MEDICAL CARE
Sub-IndustryHealth Care Technology
Trailing P/E Ratio22.3619547157771
Forward P/E Ratio23.75
Sales & Book Value
Annual Sales$5.14 billion
Price / Sales3.72
Cash Flow$3.85 per share
Price / Cash14.92
Book Value$14.40 per share
Price / Book3.99
Net Income$866.97 million
Return on Equity16.82%
Return on Assets12.20%
Cerner (NASDAQ:CERN) Frequently Asked Questions
What is Cerner's stock symbol?
Cerner trades on the NASDAQ under the ticker symbol "CERN."
How will Cerner's stock buyback program work?
Cerner announced that its Board of Directors has authorized a share buyback plan on Sunday, June 4th 2017, which allows the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 2.3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.
How were Cerner's earnings last quarter?
Cerner Co. (NASDAQ:CERN) posted its quarterly earnings results on Tuesday, February, 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by $0.03. The firm earned $1.31 billion during the quarter, compared to analysts' expectations of $1.33 billion. Cerner had a return on equity of 16.82% and a net margin of 16.86%. The business's revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 EPS. View Cerner's Earnings History.
When will Cerner make its next earnings announcement?
What guidance has Cerner issued on next quarter's earnings?
Cerner updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $2.57-2.73 for the period, compared to the Thomson Reuters consensus estimate of $2.67. The company issued revenue guidance of $5.45-5.65 billion, compared to the consensus revenue estimate of $5.57 billion.Cerner also updated its Q1 guidance to $0.57-0.59 EPS.
Where is Cerner's stock going? Where will Cerner's stock price be in 2018?
19 equities research analysts have issued twelve-month price objectives for Cerner's shares. Their predictions range from $2.82 to $80.00. On average, they expect Cerner's share price to reach $67.20 in the next year. View Analyst Ratings for Cerner.
What are Wall Street analysts saying about Cerner stock?
Here are some recent quotes from research analysts about Cerner stock:
- 1. Cantor Fitzgerald analysts commented, "Various news outlets are suggesting that President Trump will soon replace VA Secretary David Shulkin." (3/14/2018)
- 2. According to Zacks Investment Research, "Cerner has had an unfavorable run on the bourses over the last year. However, the company witnessed record bookings in the quarter and also a strong cash flow. We believe that the company has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory markets based on its product strength and enviable track record of adding new clients. Solid growth in the HealtheIntent platform also holds promise. The company performed impressively in the small hospital markets lately. On the flipside, lower margins on technology resale, resulting from higher mix of device resale is a concern. Additionally, Cerner has been facing macroeconomic challenges along with cutthroat competition in niche space. Expensive valuation and surging operating expenses also add to the woes." (2/8/2018)
- 3. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $73. Not without noise on 4Q’17 and updated guidance, CERN continues to perform in new business wins. Bookings performance was stellar, up 62% y/y on large Works wins with solid growth across many product areas. The delayed Veterans Administration signing and some pre-revenue project investment will likely pressure margins near-term, but will be more than offset on the bottom-line from the tax reform benefit. We normally would be more critical on near-term margin compression; however, given bookings strength and benefits from tax reform, we recommend investors continue to own shares and add to positions. Key positive: Bookings grew 62% to $2.3B, outperforming us and cons. both at $1.8B. 1Q’18 bookings guidance straddled our estimate and con." (2/7/2018)
Who are some of Cerner's key competitors?
Some companies that are related to Cerner include Humana (HUM), HCA Healthcare (HCA), Centene (CNC), Quest Diagnostics (DGX), Davita (DVA), Universal Health Services (UHS), Nmc Health (NMHLY), Eurofins Scientifi (ERFSF), BioM�rieux (BMXMF), WellCare Health Plans (WCG), Icon (ICLR), athenahealth (ATHN), PRA Health Sciences (PRAH), Encompass Health (EHC), MEDNAX (MD), Charles River Laboratories Intl. (CRL), Molina Healthcare (MOH) and Envision Healthcare (EVHC).
Who are Cerner's key executives?
Cerner's management team includes the folowing people:
- Brent Shafer, Chairman of the Board, Chief Executive Officer (Age 61)
- Zane M. Burke, President (Age 51)
- Clifford W. Illig, Vice Chairman of the Board (Age 66)
- Marc G. Naughton, Chief Financial Officer, Executive Vice President (Age 61)
- Michael R. Nill, Chief Operating Officer, Executive Vice President (Age 52)
- Jeffrey A. Townsend, Chief - Staff, Executive Vice President (Age 53)
- Julia M. Wilson, Chief People Officer, Executive Vice President (Age 54)
- Randy D. Sims, Chief Legal Officer, Senior Vice President, Secretary (Age 56)
- Mitchell E. Daniels Jr., Lead Independent Director (Age 68)
- Gerald E. Bisbee Jr., Ph.D., Independent Director (Age 74)
Has Cerner been receiving favorable news coverage?
Media coverage about CERN stock has been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerner earned a media sentiment score of 0.11 on Accern's scale. They also assigned news articles about the company an impact score of 44.27 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.
Who are Cerner's major shareholders?
Cerner's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.87%), Bank of New York Mellon Corp (4.94%), Generation Investment Management LLP (3.28%), Alliancebernstein L.P. (1.69%), Geode Capital Management LLC (1.13%) and American Century Companies Inc. (0.96%). Company insiders that own Cerner stock include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.
Which institutional investors are selling Cerner stock?
CERN stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Bank of New York Mellon Corp, Deutsche Bank AG, Global Thematic Partners LLC, TCW Group Inc., Arrowstreet Capital Limited Partnership, OppenheimerFunds Inc. and TIAA CREF Investment Management LLC. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.
Which institutional investors are buying Cerner stock?
CERN stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., BlackRock Inc., State of Wisconsin Investment Board, Schroder Investment Management Group, Amundi Pioneer Asset Management Inc., Nuance Investments LLC, Guggenheim Capital LLC and Standard Life Aberdeen plc. View Insider Buying and Selling for Cerner.
How do I buy shares of Cerner?
Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cerner's stock price today?
One share of CERN stock can currently be purchased for approximately $57.47.
How big of a company is Cerner?
Cerner has a market capitalization of $19.77 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.57 on an earnings per share basis. Cerner employs 26,000 workers across the globe.
How can I contact Cerner?
Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]
MarketBeat Community Rating for Cerner (CERN)MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cerner (NASDAQ:CERN) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.47||2.44||2.43||2.42|
|Ratings Breakdown: ||0 Sell Rating(s)|
10 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
10 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
12 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
12 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$67.20||$66.68||$68.81||$66.88|
|Price Target Upside: ||16.94% upside||5.04% upside||1.37% downside||3.75% downside|
Cerner (NASDAQ:CERN) Consensus Price Target History
Cerner (NASDAQ:CERN) Analyst Ratings History
(Data available from 3/22/2016 forward)
Cerner (NASDAQ:CERN) Earnings History and Estimates Chart
Cerner (NASDAQ CERN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/6/2018||Q4 2017||$0.61||$0.58||$1.33 billion||$1.31 billion||View||Listen|
|10/26/2017||Q3 2017||$0.62||$0.61||$1.29 billion||$1.28 billion||View||N/A|
|7/27/2017||Q2 2017||$0.57||$0.56||$1.30 billion||$1.29 billion||View||N/A|
|4/27/2017||Q1 17||$0.53||$0.59||$1.23 billion||$1.26 billion||View||N/A|
|2/9/2017||Q416||$0.61||$0.61||$1.26 billion||$1.26 billion||View||Listen|
|11/1/2016||Q316||$0.56||$0.55||$1.24 billion||$1.19 billion||View||Listen|
|8/2/2016||Q216||$0.57||$0.58||$1.21 billion||$1.22 billion||View||Listen|
|5/5/2016||Q1||$0.53||$0.53||$1.17 billion||$1.14 billion||View||Listen|
|2/16/2016||Q4||$0.57||$0.61||$1.17 billion||$1.18 billion||View||Listen|
|11/3/2015||Q315||$0.54||$0.54||$1.17 billion||$1.13 billion||View||Listen|
|8/4/2015||Q215||$0.52||$0.52||$1.20 billion||$1.29 billion||View||Listen|
|5/7/2015||Q115||$0.45||$0.45||$1.09 billion||$996.10 million||View||Listen|
|2/10/2015||Q414||$0.47||$0.47||$904.60 million||$926.00 million||View||Listen|
|10/23/2014||Q314||$0.42||$0.42||$855.60 million||$840.00 million||View||Listen|
|7/24/2014||Q214||$0.40||$0.40||$813.77 million||$851.80 million||View||Listen|
|4/24/2014||Q114||$0.37||$0.37||$784.72 million||$784.80 million||View||Listen|
|2/4/2014||Q413||$0.39||$0.39||$794.22 million||$793.20 million||View||Listen|
|10/24/2013||Q313||$0.35||$0.35||$757.20 million||$727.80 million||View||Listen|
|7/25/2013||Q2 2013||$0.34||$0.34||$725.71 million||$707.60 million||View||Listen|
|4/25/2013||Q1 2013||$0.63||$0.66||$708.43 million||$680.00 million||View||Listen|
|2/5/2013||Q4 2012||$0.64||$0.67||$696.52 million||$710.40 million||View||Listen|
Cerner (NASDAQ:CERN) Earnings Estimates
2018 EPS Consensus Estimate: $2.41
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Cerner (NASDAQ:CERN)
No dividend announcements for this company have been tracked by MarketBeat.com
Cerner (NASDAQ CERN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 13.11%
Institutional Ownership Percentage: 78.54%
Cerner (NASDAQ CERN) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/8/2018||Clifford W Illig||Vice Chairman||Sell||307,700||$64.52||$19,852,804.00||1,229,719|| |
|2/13/2018||Jeffrey A. Townsend||VP||Sell||230,000||$61.94||$14,246,200.00|| |
|2/8/2018||William D. Zollars||Director||Sell||4,100||$62.16||$254,856.00|| |
|12/13/2017||Michael R Battaglioli||VP||Sell||4,000||$69.89||$279,560.00||4,000|| |
|12/13/2017||Zane M. Burke||President||Sell||50,000||$70.00||$3,500,000.00|| |
|11/30/2017||Marc G. Naughton||CFO||Sell||60,000||$70.64||$4,238,400.00|| |
|11/20/2017||Clifford W Illig||Chairman||Sell||530,000||$65.54||$34,736,200.00||1,229,719|| |
|11/16/2017||Clifford W Illig||CEO||Sell||140,000||$65.52||$9,172,800.00||1,229,719|| |
|11/7/2017||Clifford W Illig||Chairman||Sell||4,000||$65.96||$263,840.00||1,229,719|| |
|9/13/2017||Michael Nill||COO||Sell||99,470||$70.45||$7,007,661.50|| |
|9/5/2017||Zane M. Burke||President||Sell||94,000||$67.47||$6,342,180.00|| |
|9/1/2017||Randy D Sims||SVP||Sell||60,000||$68.03||$4,081,800.00||60,890|| |
|8/11/2017||Clifford W Illig||Chairman||Sell||118,113||$62.03||$7,326,549.39||1,229,719|| |
|6/9/2017||Gerald E. Bisbee, Jr.||Director||Sell||6,200||$67.97||$421,414.00|| |
|6/7/2017||Julie M. Wilson||EVP||Sell||60,000||$68.15||$4,089,000.00|| |
|6/6/2017||Marc G. Naughton||CFO||Sell||60,000||$68.63||$4,117,800.00|| |
|5/22/2017||Linda M. Dillman||Director||Sell||4,600||$64.69||$297,574.00|| |
|5/12/2017||Neal L Patterson||Chairman||Sell||43,000||$64.33||$2,766,190.00|| |
|5/11/2017||Clifford W Illig||Vice Chairman||Sell||234,525||$64.43||$15,110,445.75||1,229,719|| |
|5/8/2017||Neal L Patterson||Chairman||Sell||180,667||$64.71||$11,690,961.57|| |
|5/4/2017||Denis A Cortese||Director||Sell||1,550||$64.39||$99,804.50|| |
|5/4/2017||Michael Nill||COO||Sell||110,000||$63.91||$7,030,100.00|| |
|5/1/2017||Michael R Battaglioli||VP||Sell||4,000||$65.55||$262,200.00||4,000|| |
|3/14/2017||Neal L Patterson||Chairman||Sell||20,000||$54.91||$1,098,200.00|| |
|2/13/2017||Jeffrey A. Townsend||VP||Sell||100,000||$52.31||$5,231,000.00|| |
|11/7/2016||William D. Zollars||Director||Sell||10,000||$51.50||$515,000.00|| |
|9/6/2016||Linda M. Dillman||Director||Sell||6,000||$64.68||$388,080.00|| |
|8/18/2016||Clifford W Illig||Vice Chairman||Sell||325,705||$65.10||$21,203,395.50||6,652,392|| |
|8/10/2016||Zane M. Burke||President||Sell||149,480||$66.73||$9,974,800.40|| |
|8/9/2016||Neal L Patterson||Chairman||Sell||428,638||$67.14||$28,778,755.32|| |
|8/8/2016||Julie M. Wilson||EVP||Sell||46,923||$67.27||$3,156,510.21|| |
|8/8/2016||Michael Nill||COO||Sell||50,000||$67.16||$3,358,000.00|| |
|8/8/2016||Michael R Battaglioli||VP||Sell||2,000||$67.34||$134,680.00||2,000|| |
|6/1/2016||William D Zollars||Director||Sell||9,000||$55.72||$501,480.00||44,486|| |
|5/23/2016||Linda M Dillman||Director||Sell||3,700||$54.46||$201,502.00||34,243|| |
|5/12/2016||Neal L Patterson||CEO||Sell||40,000||$54.24||$2,169,600.00|| |
|2/19/2016||Jeffrey A. Townsend||VP||Sell||100,000||$51.48||$5,148,000.00|| |
|2/19/2016||William D. Zollars||Director||Sell||11,680||$51.40||$600,352.00|| |
|12/14/2015||Julie M. Wilson||EVP||Sell||2,821||$60.52||$170,726.92||32,895|| |
|12/10/2015||Michael R. Battaglioli||CAO||Sell||2,000||$60.06||$120,120.00|| |
|6/3/2015||Clifford W Illig||Vice Chairman||Sell||20,261||$67.59||$1,369,440.99|| |
|6/3/2015||Neal L Patterson||CEO||Sell||252,340||$67.37||$17,000,145.80|| |
|5/26/2015||Denis A Cortese||Director||Sell||4,000||$67.52||$270,080.00|| |
|5/20/2015||Gerald E Bisbee Jr||Director||Sell||6,400||$68.40||$437,760.00|| |
|5/19/2015||Linda M Dillman||Director||Sell||5,900||$68.63||$404,917.00|| |
|5/12/2015||William D Zollars||Director||Sell||7,400||$67.63||$500,462.00|| |
|3/9/2015||Michael Nill||COO||Sell||50,000||$70.45||$3,522,500.00|| |
|3/2/2015||Zane M Burke||President||Sell||50,000||$71.85||$3,592,500.00|| |
|2/27/2015||Jeffrey A Townsend||VP||Sell||120,000||$72.13||$8,655,600.00|| |
|2/25/2015||Neal L Patterson||CEO||Sell||54,000||$73.00||$3,942,000.00|| |
|2/19/2015||Randy D Sims||SVP||Sell||28,874||$71.11||$2,053,230.14|| |
|2/18/2015||Neal L Patterson||CEO||Sell||325,492||$70.06||$22,803,969.52|| |
|2/13/2015||Marc G Naughton||CFO||Sell||40,000||$70.95||$2,838,000.00|| |
|2/13/2015||Michael R Battaglioli||CAO||Sell||2,000||$70.92||$141,840.00|| |
|2/13/2015||Randy D Sims||SVP||Sell||31,126||$71.06||$2,211,813.56|| |
|12/1/2014||Julie M Wilson||EVP||Sell||22,000||$64.58||$1,420,760.00|| |
|11/26/2014||Clifford W Illig||Chairman||Sell||124,084||$63.44||$7,871,888.96|| |
|11/25/2014||Clifford W Illig||Chairman||Sell||2,900||$64.50||$187,050.00|| |
|11/18/2014||Clifford W Illig||Chairman||Sell||116,586||$64.51||$7,520,962.86|| |
|11/6/2014||Randy D Sims||SVP||Sell||43,162||$63.65||$2,747,261.30|| |
|11/4/2014||Randy D Sims||SVP||Sell||26,838||$63.51||$1,704,481.38|| |
|11/3/2014||William D Zollars||Director||Sell||7,900||$63.30||$500,070.00|| |
|10/28/2014||Michael Nill||COO||Sell||50,000||$62.72||$3,136,000.00|| |
|9/8/2014||Julie M Wilson||EVP||Sell||16,000||$59.53||$952,480.00|| |
|9/3/2014||Michael R Battaglioli||CAO||Sell||2,000||$59.21||$118,420.00|| |
|8/13/2014||Neal L Patterson||CEO||Sell||54,000||$56.38||$3,044,520.00|| |
|8/8/2014||William D Zollars||Director||Sell||9,200||$55.20||$507,840.00|| |
|5/30/2014||Denis A Cortese||Director||Sell||4,000||$54.42||$217,680.00|| |
|3/11/2014||Neal Patterson||CEO||Sell||231,000||$60.31||$13,931,610.00|| |
|2/14/2014||Neal Patterson||CEO||Sell||15,000||$59.90||$898,500.00|| |
|2/13/2014||Michael Nill||COO||Sell||50,000||$57.94||$2,897,000.00||81,612|| |
|2/10/2014||Michael Battaglioli||CAO||Sell||2,000||$56.08||$112,160.00|| |
|11/8/2013||Marc Naughton||CFO||Sell||40,000||$56.57||$2,262,800.00||71,542|| |
|11/7/2013||Neal Patterson||CEO||Sell||4,000||$55.67||$222,680.00|| |
|11/1/2013||Zane M Burke||President||Sell||39,000||$55.98||$2,183,220.00|| |
|10/30/2013||Michael R Battaglioli||CAO||Sell||2,400||$56.85||$136,440.00|| |
|9/12/2013||Julie Wilson||EVP||Sell||58,000||$48.57||$2,817,060.00||10,522|| |
|9/12/2013||Michael Nill||COO||Sell||48,320||$48.77||$2,356,566.40||81,612|| |
|8/1/2013||Marc G Naughton||CFO||Sell||80,000||$49.50||$3,960,000.00|| |
|8/1/2013||Neal L Patterson||CEO||Sell||1,000||$49.59||$49,590.00|| |
|6/12/2013||Denis A Cortese||Director||Sell||2,000||$98.00||$196,000.00|| |
|5/23/2013||William D Zollars||Director||Sell||10,540||$95.60||$1,007,624.00|| |
|5/17/2013||Neal L Patterson||CEO||Sell||30,000||$97.05||$2,911,500.00|| |
|5/15/2013||Julie M Wilson||EVP||Sell||28,000||$96.61||$2,705,080.00|| |
|5/14/2013||Neal L Patterson||CEO||Sell||15,000||$95.38||$1,430,700.00|| |
|5/9/2013||Jeffrey A Townsend||VP||Sell||195,664||$94.98||$18,584,166.72|| |
Cerner (NASDAQ CERN) News Headlines
Cerner (NASDAQ:CERN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cerner (NASDAQ:CERN) Income Statement, Balance Sheet and Cash Flow Statement
Cerner (NASDAQ CERN) Stock Chart for Thursday, March, 22, 2018